Article thumbnail

Adenosine and Immune Imbalance in Visceral Leishmaniasis: The Possible Role of Ectonucleotidases

By Rafael Paletta-Silva and José Roberto Meyer-Fernandes


Visceral leishmaniasis (VL) is the most severe form of leishmaniasis and is responsible for most Leishmania-associated deaths. VL represents a serious public health problem that affects many countries. The immune response in leishmaniasis is very complex and is poorly understood. The Th1 versus Th2 paradigm does not appear to be so clear in visceral leishmaniasis, suggesting that other immunosuppressive or immune-evasion mechanisms contribute to the pathogenesis of VL. It has been demonstrated that generation of adenosine, a potent endogenous immunosuppressant, by extracellular enzymes capable to hydrolyze adenosine tri-nucleotide (ATP) at the site of infection, can lead to immune impairment and contribute to leishmaniasis progression. In this regard, this paper discusses the unique features in VL immunopathogenesis, including a possible role for ectonucleotidases in leishmaniasis

Topics: Review Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2001). A Mg-dependent ecto-ATPase in Leishmania amazonensis and its possible role in adenosine acquisition and virulence,”
  2. (2008). A2A receptors in inflammation and injury: lessons learned from transgenic animals,”
  3. (2007). Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression,”
  4. (2009). Adenosine: an endogenous modulator of innate immune system with therapeutic potential,”
  5. (2010). Basal release of ATP: an autocrine-paracrine mechanism for cell regulation,”
  6. (1993). Characterization of developmentally-regulated nucleases in promastigotes and amastigotes of Leishmania mexicana,”
  7. (1997). Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis,”
  8. (2001). Comparison of the potency of adenosine as an agonist at human adenosinereceptorsexpressedinChinesehamsterovarycells,”
  9. (2006). Cronstein,andP.C.Dagnelie,“Adenosine5-triphosphateand adenosine as endogenous signaling molecules
  10. (1984). D.M.DwyerandM.Gottlieb,“Surfacemembranelocalization of 3’- and 5’-nucleotidase activities in Leishmania donovani promastigotes,”
  11. (2006). Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide,” J o u r n a lo fL e u k o c y t eB i o l o g y ,
  12. (2002). Ecto-ATPases in protozoa parasites: looking for a function,”
  13. (2010). Ecto-nucleoside triphosphate diphosphohydrolase activities in trypanosomatids: possible roles in infection,
  14. (2008). ExtracellularnucleotidemetabolisminLeishmania:influence of adenosine in the establishment of infection,”
  15. (1992). G.O.GbenleandD.M.Dwyer,“Purificationandpropertiesof 3’-nucleotidase of Leishmania donovani,”
  16. (2005). GS protein-coupled adenosine receptor signaling and lytic function of activated NK cells,”
  17. High concentration of adenosine in human visceral leishmaniasis: despite increased ADA and decreased CD73,” Parasite Immunology.
  18. Identification and characterization of a new Leishmania major specific 3nucleotidase/nuclease protein,”
  19. (2009). Identification of regulatory T cells during experimental Leishmania infantum infection,”
  20. (2011). Immune and inflammatory responses to Leishmania amazonensis isolated from different clinical forms of human leishmaniasis
  21. (2007). Immune response to Leishmania: paradox rather than paradigm,”
  22. (1996). Interleukin-12 restores interferon-γ production and cytotoxic responses in visceral leishmaniasis,”
  23. (2006). K r e c k l e r ,T .C .W a n ,Z .D .G e ,a n dJ .A .A u c h a m p a c h , “Adenosine inhibits tumor necrosis factor-α release from mouse peritoneal macrophages via A2A and A2B but not the A 3 adenosine receptor,”
  24. (2006). Leishmania amazonensis: biological and biochemical characterization of ecto-nucleoside triphosphate diphosphohydrolase activities,”
  25. Leishmania amazonensis: characterization of an ecto-3-nucleotidase activity and its possible role in virulence,” Experimental Parasitology.
  26. M u r r a y ,J .D .B e r m a n ,C .R .D a v i e s ,a n dN .G .S a r a v i a ,
  27. (2010). M.Mandapathil,B.Hilldorfer,M.J.Szczepanskietal.,“Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T Cells,”
  28. (2008). Macrophage and T-cell gene expression in a model of early infection with the protozoan Leishmania chagasi,”
  29. (2004). Macrophage hypo-responsiveness to interferon-γ in aged mice is associated with impaired signaling through
  30. (2008). Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A2B receptor,”
  31. (2006). Multiplex analysis of circulating cytokines in the sera of patients with different clinical forms of visceral leishmaniasis,” Cytometry Part A,v o l .6 9 ,n o .5 ,p p .
  32. (2010). N .C o s t a ,G .L .W e r n e c k ,D .L .C o s t ae ta l . ,“ I ss e v e r e visceral leishmaniasis a systemic inflammatory response syndrome? A case control study,” Revista da Sociedade Brasileira de Medicina Tropical,
  33. (1994). Nomenclature and classification of purinoceptors,”
  34. (2008). Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade,”
  35. (1996). P2 purinoceptors: historical perspective and classification,”
  36. (2003). Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family,”
  37. (1981). Protozoan parasite of humans:
  38. (2007). S.Nyl´ enandD.Sacks,“Interleukin-10andthepathogenesisof human visceral leishmaniasis,” Trends in Immunology,
  39. (2003). Secretion of IL-2 and IFN-γ,b u tn o tI L - 4 ,b y antigen-specific T cells requires extracellular ATP,”
  40. (2005). T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani,”
  41. (1990). Tissue levels, source, and regulation of 3’-AMP: an intracellular inhibitor of adenylyl cyclases,”
  42. (2011). V i e i r a ,R .P a l e t t a - S i l v a ,E .M .S a r a i v a
  43. (2002). Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda,” The Lancet Infectious Diseases,
  44. (2007). Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?”
  45. (1998). W i l s o n ,B .M .Y o u n g ,B .L .D a v i d s o n ,K .A .M e n t e ,a n d
  46. (2011). W.G.Junger,“Immunecellregulationbyautocrinepurinergic signalling,” Nature Reviews Immunology,v o l .1 1 ,n o .3 ,p p .

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.